(Q39257245)

English

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study (English)

1 reference

Europe PubMed Central

10 September 2017

0 references

anti-retroviral agent

0 references

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

1

object named as

Amanda Mocroft

1 reference

Europe PubMed Central

10 September 2017

Antonella d'Arminio Monforte

8

object named as

Antonella d'Arminio Monforte

1 reference

Europe PubMed Central

10 September 2017

10

object named as

Lene Ryom

1 reference

Europe PubMed Central

10 September 2017

object named as

Jens D Lundgren

2

0 references

Tomasz Smiatacz

0 references

9

object named as

Ole Kirk

1 reference

Europe PubMed Central

10 September 2017

5

object named as

Peter Reiss

1 reference

Europe PubMed Central

10 September 2017

Christoph A Fux

4

object named as

Christoph A Fux

1 reference

Europe PubMed Central

10 September 2017

Olivier Moranne

6

object named as

Olivier Moranne

1 reference

Europe PubMed Central

10 September 2017

Phillipe Morlat

7

object named as

Philippe Morlat

1 reference

Europe PubMed Central

10 September 2017

author name string

Michael Ross

3

1 reference

Europe PubMed Central

10 September 2017

Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study

11

1 reference

Europe PubMed Central

10 September 2017

publication date

17 November 2015

1 reference

Europe PubMed Central

10 September 2017

The lancet. HIV

1 reference

Europe PubMed Central

10 September 2017

3

1 reference

Europe PubMed Central

10 September 2017

1

1 reference

Europe PubMed Central

10 September 2017

e23-32

1 reference

Europe PubMed Central

10 September 2017

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV and CKD epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic kidney disease—a challenge for all ages

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lopinavir-ritonavir (Kaletra) and lithiasis: seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of tenofovir exposure with kidney disease risk in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: analysis of week 96 resul

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chapter 1: Definition and classification of CKD

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900211-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2352-3018(15)00211-8

1 reference

Europe PubMed Central

10 September 2017

release_e2d2xkr3gncsjorjxd7zdkyfxu

0 references

1 reference

Europe PubMed Central

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39257245&oldid=2079294274"